Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT

24 Jan 2019

Abstract excerpt

A recent approach for limiting production of pro-inflammatory cytokines has been to target bromodomain and extra-terminal (BET) proteins. These epigenetic readers of histone acetylation regulate transcription of genes involved in inflammation, cardiovascular disease, and cancer. Development of BET inhibitors (BETi) has generated enormous interest for their therapeutic potential. Because inflammatory signals and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Cell Function and Interaction
Share to Multiple Myeloma Research and Treatments
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30733722
DOI: 10.3389/fimmu.2018.03104

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCTPMID 30733722Read ↗

BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in miceSemantic proximity Read ↗

Domain-selective targeting of BET proteins in cancer and immunological diseasesSemantic proximity Read ↗

Integrated Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of Acute Graft-versus-Host-DiseaseSemantic proximity Read ↗

Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in miceSemantic proximity Read ↗

Regulatory T cell therapy for Graft-versus-Host DiseaseSemantic proximity Read ↗

BET bromodomain inhibition suppresses TH17-mediated pathologySemantic proximity Read ↗

BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells.Semantic proximity Read ↗

BACH2: The Future of Induced T-Regulatory Cell TherapiesSemantic proximity Read ↗

Analysis of the T-cell repertoire and transcriptome identifies mechanisms of regulatory T-cell suppression of GVHDSemantic proximity Read ↗

CD3e-immunotoxin spares CD62L <sup>lo</sup> Tregs and reshapes organ-specific T-cell composition by preferentially depleting CD3e <sup>hi</sup> T cellsSemantic proximity Read ↗

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and ChallengesSemantic proximity Read ↗

T-bet+ B Cells in Humans: Protective and Pathologic FunctionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.